PGM5P4: A Potential Drug Target for Cellular Signaling (G729468)

Target Name: PGM5P4

NCBI ID: G729468

PGM5P4

Other Name(s): LOC729468 | phosphoglucomutase 5 pseudogene 4 | Putative PGM5-like protein 1 | Uncharacterized protein LOC729468

PGM5P4: A Potential Drug Target for Cellular Signaling

Post-translational modification (PTM) is a critical process in cellular signaling that plays a central role in the regulation of gene expression and cellular growth. The poly (A) site in eukaryotic mRNAs is a site of frequent PTMs, including tyrosination, methylation, and ubiquitination, which are involved in the regulation of protein stability, localization, and interactions with other cellular components. One of the key post-translational modification (PTM) enzymes involved in the regulation of the poly (A) site is poly (A) richly expressed (PARP) 1 (PARP1), also known as PGM5P4. PGM5P4 is a non-protein protein that contains a single domain, which is composed of a nucleotide-binding oligomerization (NBO) domain and a transmembrane region. PGM5P4 is highly expressed in various tissues and is involved in the regulation of gene expression, including the control of cell cycle progression and apoptosis.

In this article, we will focus on PGM5P4, a drug target (or biomarker) that is involved in the regulation of gene expression and cellular signaling. We will explore the structure and function of PGM5P4, its role in the regulation of the poly (A) site, and its potential as a drug target.

Structure and Function

PGM5P4 is a non-protein protein that contains a single domain, which is composed of a nucleotide-binding oligomerization (NBO) domain and a transmembrane region. The NBO domain is responsible for the binding of nucleotides to the protein, while the transmembrane region is responsible for the protein's trafficking and localization to various cellular compartments.

The NBO domain of PGM5P4 contains a nucleotide-binding oligomerization (NBO) domain that is composed of a nucleotide-binding oligomerization (NBO) domain and a carboxylic acid region. The NBO domain is responsible for the binding of nucleotides to the protein. The NBO domain of PGM5P4 contains several distinct regions, including a nucleotide-binding oligomerization (NBO) domain that is composed of a nucleotide-binding oligomerization (NBO) domain and a carboxylic acid region. The NBO domain of PGM5P4 contains several distinct regions, including a nucleotide-binding oligomerization (NBO) domain that is composed of a nucleotide-binding oligomerization (NBO) domain and a carboxylic acid region. The NBO domain of PGM5P4 contains several distinct regions, including a nucleotide-binding oligomerization (NBO) domain that is composed of a nucleotide-binding oligomerization (NBO) domain and a carboxylic acid region.

The transmembrane region of PGM5P4 is responsible for the protein's trafficking and localization to various cellular compartments. The transmembrane region of PGM5P4 is responsible for the protein's trafficking and localization to various cellular compartments.

Function

PGM5P4 is involved in the regulation of gene expression and cellular signaling. It is a key post-translational modification (PTM) enzyme involved in the regulation of the poly (A) site, which is a site of frequent PTMs, including tyrosination, methylation, and ubiquitination, that are involved in the regulation of protein stability, localization, and interactions with other cellular components.

PGM5P4 is highly expressed in various tissues and is involved in the regulation of gene expression, including the control of cell cycle progression and apoptosis. PGM5P4 is a potential drug target (or biomarker) that can be targeted by small molecules to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Conclusion

PGM5P4 is a non-protein protein that contains a single domain, which is composed of a nucleotide-binding oligomerization (NBO) domain and a transmembrane region. PGM5P4 is highly expressed in various tissues and is involved in the regulation of gene expression, including the control of cell cycle progression and apoptosis. It is a potential drug target (or biomarker) that can be targeted by small molecules to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Further research is needed to fully understand the role of PGM5P4 in cellular signaling and its potential as a drug target.

Protein Name: Phosphoglucomutase 5 Pseudogene 4

The "PGM5P4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PGM5P4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets